Implementing a Faculty Diversity, Equity, and Inclusion Strategic Plan Using a Quality Improvement Approach. The Journal of Pediatrics. 2025; 276:114374.
.Disparities in adolescent controller medication adherence, treatment barriers, and asthma control. Pediatric Pulmonology. 2024; 59:3288-3297.
.2024; 1.
. A health equity ECHO for clinicians of individuals with SCD.2024; 144:1066.
. Community Health Worker and Mobile Health Programs to Help Young Adults with Sickle Cell Disease Transition to Using Adult Healthcare Services – the Comets Study; Results from Patient-Reported Outcomes at 6 Months. Blood.2024; 144:3693.
. Prospective Biopsychosocial Impacts of Stress and Disease Stigma Among Adolescents and Young Adults with Sickle Cell Disease. Blood.2024; 144:605.
. Empowering Adolescents and Young Adults with Sickle Cell Disease: Development of a Shared Decision-Making Toolkit for Disease-Modifying Therapies. Blood.2024; 144:1067.
. Acceptability and Feasibility of Salivary Stress Research with Adolescents and Young Adults with Sickle Cell Disease. Blood.2024; 144:7524.
. Community-Engaged Research in Psychological Interventions for Pediatric Sickle Cell Disease: A Scoping Review. Blood.2024; 144:5360.
. Location, Location(s), Location(s+): Moving from Acute to Chronic Pain in SCD Pain in School-Age Children. Blood.Feasibility of a clinic-based, multicomponent hydroxyurea adherence intervention for adolescents and young adults with sickle cell disease. Pediatric Blood and Cancer. 2024; 71:e31144.
.The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study. Pediatric Blood and Cancer. 2024; 71:e31156.
.Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement. JAMA network open. 2024; 7:e2429443.
.Attitudes, Beliefs, and Intention to Receive a COVID-19 Vaccine for Pediatric Patients With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. 2024; 46:e305-e312.
.The Physician's Calling and Science Promote Health Equity and Outcomes-Reply. JAMA pediatrics. 2024; 178:729-730.
.Development of a multimodal geomarker pipeline to assess the impact of social, economic, and environmental factors on pediatric health outcomes. Journal of the American Medical Informatics Association : JAMIA. 2024; 31:1471-1478.
.Disease-modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults. Pediatric Blood and Cancer. 2024; 71:e30999.
.2024; 1.
. A Health Equity ECHO Learning Series for Interdisciplinary Providers.Trajectory of Sleep, Depression, and Quality of Life in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2024; 30:632.e1-632.e5.
.Factors Associated With Racially and Ethnically Diverse Sample of Adolescents, Young Adults, and Parents' Intention to Receive a COVID-19 Vaccine. American Journal of Health Promotion. 2024; 38:672-682.
.An Updated Equitable Model of Readiness for Transition to Adult Care: Content Validation in Young People With Sickle Cell Disease. JAMA pediatrics. 2024; 178:274-282.
.2024; 12:1-15.
. Recommendations on Inclusive Language and Transparent Reporting Relating to Diversity Dimensions for the Journal of Pediatric Psychology and Clinical Practice in Pediatric Psychology. Clinical Practice in Pediatric Psychology.Editorial: Recommendations on inclusive language and transparent reporting relating to diversity dimensions for the Journal of Pediatric Psychology and Clinical Practice in Pediatric Psychology. Journal of Pediatric Psychology. 2024; 49:1-12.
.Development of the iManage SCD mobile health application for transition. 2024; 2:100074.
.Feasibility of Electronic Medication Monitoring Among Adolescents and Emerging Adults with Sickle Cell Disease. Patient Preference and Adherence. 2023; 17:3167-3171.
.2023; 1:54.
. The effect of an adapted digital mental health intervention for sickle cell disease on engagement: a pilot randomized controlled trial.Evaluation of a Community COVID-19 Vaccine Ambassador Train-the-Trainer Program. Journal of Immigrant Health. 2023; 25:1302-1306.
.2023; 142:5054.
. Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need?. Blood.2023; 142:7199.
. SCD and COVID-19 Vaccines: What Do Pediatric Patients Want to Know?. Blood.2023; 142:7198.
. Patterns of Nonadherence to Hydroxyurea in Pediatric Sickle Cell Disease. Blood.2023; 142:5059.
. Disease-Modifying Therapies for Sickle Cell Disease: Decisional Needs and Supports Among Adolescents and Young Adults. Blood.2023; 142:371.
. Assessing Psychosocial Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement. Blood.A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD. Blood Advances. 2023; 7:6184-6190.
.Partnering with Families and Communities to Improve Child Health and Health Equity. Pediatric Clinics of North America. 2023; 70:683-693.
.Social determinants of health: the next frontier for improving care and outcomes in sickle cell disease. The Lancet Haematology. 2023; 10:e571-e573.
.Understanding Barriers and Facilitators of Attention-Deficit/Hyperactivity Disorder Treatment Initiation and Adherence in Black and Latinx Children. Academic Pediatrics. 2023; 23:1175-1186.
.Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease. Clinical Trials. 2023; 20:211-222.
.School Challenges and Services Related to Executive Functioning for Fully Included Middle Schoolers with Autism. Focus on Autism and Other Developmental Disabilities. 2023; 38:90-100.
.Virtual reality informs clinical observation tool. The Clinical Teacher. 2023; 20:e13575.
.Diversity, Equity, and Inclusion within Pediatric Adherence Science. Journal of Clinical Psychology in Medical Settings. 2023; 30:330-341.
.Overcoming Vaccine Hesitancy Using Community-Based Efforts. Pediatric Clinics of North America. 2023; 70:359-370.
.Psychologists as leaders in equitable science: Applications of antiracism and community participatory strategies in a pediatric behavioral medicine clinical trial. American Psychologist. 2023; 78:107-118.
.A Virtual Reality Curriculum to Enhance Residents' Behavioral Health Anticipatory Guidance Skills: A Pilot Trial. Academic Pediatrics. 2023; 23:185-192.
.Family-centered communication in pediatric sickle cell disease. Pediatric Blood and Cancer. 2022; 69:e30016.
.2022; 140:13141-13142.
. A Health Equity Echo for Providers of Children and Adults with Sickle Cell Disease. Blood.2022; 140:7898-7899.
. A New Phen X Collection: Sickle Cell Disease Psychosocial and Social Determinants of Health Protocols. Blood.2022; 140:10857-10859.
. Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia. Blood.2022; 140:7875-7876.
. Hydroxyurea Use Among Youth with Sickle Cell Anemia across Eight Care Centers within the United States. Blood.Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations. Pediatric Research. 2022; 92:966-978.
.Partnering With Faith-Based Organizations to Offer Flu Vaccination and Other Preventive Services. Pediatrics. 2022; 150:e2022056193.
.COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults. Journal of Pediatric Psychology. 2022; 47:631-640.
.Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease. Frontiers in Neurology. 2022; 13:835823.
.The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease. Ethnicity and Health. 2022; 27:833-846.
.Factors Associated With Participation in Clinical Trials Among Patients With Lupus. Journal of Clinical Rheumatology: practical reports on rheumatic and musculoskeletal disease. 2022; 28:132-136.
.An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia. Journal of Pediatric Hematology/Oncology. 2022; 44:e799-e803.
.An Exploration of Social Norms That Restrict Girls' Sexuality and Facilitate Child Marriage in Bangladesh to Inform Policies and Programs. Journal of Adolescent Health. 2022; 70:S17-S21.
.2022; 7:115-124.
. Assessment of Competency-Based Behavioral Health Anticipatory Guidance Skills Among Pediatric Residents: the Role of Virtual Reality. Journal of Technology in Behavioral Science.Editor, Schurman JV; Duncan CL. Clinical Practice in Pediatric Psychology. 2022; 10:79-90.
. Perceptions of a Self-Management Intervention for Adolescents With Sickle Cell Disease.Mobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease. Translational Behavioral Medicine. 2021; 11:1823-1831.
.Pain-Related Injustice Appraisals in Youth with Sickle Cell Disease: A Preliminary Investigation. Pain Medicine. 2021; 22:2207-2217.
.Attitudes About COVID-19 and Health (ATTACH): Online Survey and Mixed Methods Study. JMIR Mental Health. 2021; 8:e29963.
.A Virtual Reality Resident Training Curriculum on Behavioral Health Anticipatory Guidance: Development and Usability Study. JMIR Pediatrics and Parenting. 2021; 4:e29518.
.Neurodevelopmental and psychosocial interventions for individuals with CHD: a research agenda and recommendations from the Cardiac Neurodevelopmental Outcome Collaborative. Cardiology in the Young. 2021; 31:888-899.
.Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial. JMIR Research Protocols. 2021; 10:e27650.
.Weight status and health behaviors of adolescents and young adults with sickle cell disease: The emerging risk for obesity. Pediatric Hematology-Oncology (Informa). 2021; 38:265-271.
.Development and Psychometric Evaluation of the PROMIS Pediatric Pain Intensity Measure in Children and Adolescents with Chronic Pain. Journal of Pain. 2021; 22:48-56.
.